Global Lung Cancer Therapeutics Market

1. Summary

The Global Lung Cancer Therapeutics Market was valued at $36.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 9.8% CAGR, to an estimated market size of $58.3 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global lung cancer therapeutics market includes pharmaceutical and biological interventions such as targeted therapies, immunotherapies, and chemotherapy used to treat non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). The scope excludes standalone diagnostic equipment but includes the integration of precision medicine and biomarker-driven drug delivery.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Lung Cancer Therapeutics Market in the period 2025-30:

• The market is experiencing a significant shift toward precision medicine, utilizing biomarker-based treatments for specific genetic mutations like EGFR, ALK, and KRAS.
• Widespread adoption of immunotherapy, particularly checkpoint inhibitors like PD-1/PD-L1, is becoming the foundational standard for first-line treatment.
• Deepening integration with advanced diagnostics, such as Next-Generation Sequencing (NGS) and liquid biopsies, allows for real-time monitoring of treatment response.
• Rising global incidence of lung cancer is driven by environmental factors, pollution, and aging populations in developed regions like Germany and Japan.
• Increasing use of combination regimens, pairing immunotherapies with traditional platinum-doublet chemotherapy to enhance efficacy.
• Expanded low-dose CT screening programs are leading to higher rates of early-stage detection, shifting the therapeutic focus toward adjuvant and neo-adjuvant settings.
• Technological innovation is successfully targeting previously "undruggable" mutations, specifically within the RAS gene family and KRAS G12C segments.

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments: